Výsledky vyhledávání - Marzia Capelletti
- Zobrazuji výsledky 1 - 20 z 38
- Přejít na další stránku
-
1
-
2
Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer Autor L. Flores, David W. Kindelberger, Azra H. Ligon, Marzia Capelletti, Mario V. Fiorentino, Massimo Loda, Edmund S. Cibas, Pasi A. Jänne, Ian E. Krop
Vydáno 2010Artigo -
3
-
4
Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway Autor Alexis B. Cortot, Claire E. Repellin, Takeshi Shimamura, Marzia Capelletti, Kreshnik Zejnullahu, Dalia Ercan, James G. Christensen, Kwok‐Kin Wong, Nathanael S. Gray, Pasi A. Jänne
Vydáno 2012Artigo -
5
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/<i>neu</i>–Positive Metastatic Breast Cancer Autor Antonino Musolino, Nadia Naldi, Beatrice Bortesi, Debora Pezzuolo, Marzia Capelletti, Gabriele Missale, Diletta Laccabue, Alessandro Zerbini, Roberta Camisa, Giancarlo Bisagni, Tauro Maria Neri, Andrea Ardizzoni
Vydáno 2008Artigo -
6
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer Autor Erin M. Tricker, Chunxiao Xu, Sharmeen Uddin, Marzia Capelletti, Dalia Ercan, Atsuko Ogino, Christine A. Pratilas, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne
Vydáno 2015Artigo -
7
Identification of Existing Drugs That Effectively Target <i>NTRK1</i> and <i>ROS1</i> Rearrangements in Lung Cancer Autor Curtis R. Chong, Magda Bahcall, Marzia Capelletti, Takayuki Kosaka, Dalia Ercan, Taebo Sim, Lynette M. Sholl, Mizuki Nishino, Bruce E. Johnson, Nathanael S. Gray, Pasi A. Jänne
Vydáno 2016Artigo -
8
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines Autor Silvia La Monica, Maricla Galetti, Roberta Alfieri, Andrea Cavazzoni, Andrea Ardizzoni, Marcello Tiseo, Marzia Capelletti, Matteo Goldoni, Sara Tagliaferri, Antonio Mutti, Claudia Fumarola, Mara Bonelli, Daniele Generali, Pier Giorgio Petronini
Vydáno 2009Artigo -
9
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor Autor Dalia Ercan, Kreshnik Zejnullahu, Kimio Yonesaka, Yun Xiao, Marzia Capelletti, Andrew M. Rogers, Eugene Lifshits, Alyssa Brown, Charles Lee, James G. Christensen, David J. Kwiatkowski, Jeffrey A. Engelman, Pasi A. Jänne
Vydáno 2010Artigo -
10
<i>EGFR</i> Exon 19 Insertions: A New Family of Sensitizing <i>EGFR</i> Mutations in Lung Adenocarcinoma Autor Mai He, Marzia Capelletti, Khédoudja Nafa, Cai‐Hong Yun, Maria E. Arcila, Vincent A. Miller, Michelle S. Ginsberg, Binsheng Zhao, Mark G. Kris, Michael J. Eck, Pasi A. Jänne, Marc Ladanyi, Geoffrey R. Oxnard
Vydáno 2011Artigo -
11
Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Tr... Autor Pasi A. Jänne, Xiaofei Wang, Mark A. Socinski, Jeffrey Crawford, Thomas E. Stinchcombe, Lin Gu, Marzia Capelletti, Martin J. Edelman, Miguel A. Villalona‐Calero, Robert A. Kratzke, Everett E. Vokes, Vincent A. Miller
Vydáno 2012Artigo -
12
The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers Autor Takaaki Sasaki, Katsuhiro Okuda, Wei Zheng, James E. Butrynski, Marzia Capelletti, Liping Wang, Nathanael S. Gray, Keith D. Wilner, James G. Christensen, George D. Demetri, Geoffrey I. Shapiro, Scott J. Rodig, Michael J. Eck, Pasi A. Jänne
Vydáno 2010Artigo -
13
Intratumoral Heterogeneity in <i>EGFR</i>-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition Autor Margaret Soucheray, Marzia Capelletti, Inés Pulido, Yanan Kuang, Cloud P. Paweletz, Jeffrey H. Becker, Eiki Kikuchi, Chunxiao Xu, Tarun B. Patel, Fátima Al‐Shahrour, Julián Carretero, Kwok‐Kin Wong, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura
Vydáno 2015Artigo -
14
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors Autor Takayuki Kosaka, Junko Tanizaki, Raymond M. Paranal, Hideki Endoh, Christine Lydon, Marzia Capelletti, Claire E. Repellin, Jihyun Choi, Atsuko Ogino, Antonio Calles, Dalia Ercan, Amanda J. Redig, Magda Bahcall, Geoffrey R. Oxnard, Michael J. Eck, Pasi A. Jänne
Vydáno 2017Artigo -
15
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M Autor Wenjun Zhou, Dalia Ercan, Liang Chen, Cai‐Hong Yun, Danan Li, Marzia Capelletti, Alexis B. Cortot, Lucian R. Chirieac, Roxana E. Iacob, Robert F. Padera, John R. Engen, Kwok‐Kin Wong, Michael J. Eck, Nathanael S. Gray, Pasi A. Jänne
Vydáno 2009Artigo -
16
Identification of Recurrent <i>FGFR3–TACC3</i> Fusion Oncogenes from Lung Adenocarcinoma Autor Marzia Capelletti, Michael Dodge, Dalia Ercan, Peter S. Hammerman, Seung-Il Park, Young Tae Kim, Hidefumi Sasaki, David M. Jablons, Doron Lipson, Lauren Young, Phil Stephens, Vincent A. Miller, Neal I. Lindeman, Kiara J. Munir, William G. Richards, Pasi A. Jänne
Vydáno 2014Artigo -
17
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS Autor Chiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, Haiyun Wang, Raymond M. Paranal, Jiaqi Li, Marzia Capelletti, Cristina Caffarra, Shuai Li, Qi Lv, Sudershan Reddy Gondi, John C. Hunter, Jia Lu, Roberto Chiarle, David Santamarı́a, Kenneth D. Westover, Pasi A. Jänne
Vydáno 2018Artigo -
18
Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance Autor Neil Johnson, Shawn F. Johnson, Wei Yao, Yu-Chen Li, Young-Eun Choi, Andrea J. Bernhardy, Yifan Wang, Marzia Capelletti, Kristopher A. Sarosiek, Lisa A. Moreau, Dipanjan Chowdhury, Anneka Wickramanayake, Maria I. Harrell, Joyce F. Liu, Alan D. D’Andrea, Alexander Miron, Elizabeth M. Swisher, Geoffrey I. Shapiro
Vydáno 2013Artigo -
19
A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer Autor Frederick H. Wilson, Cory M. Johannessen, Federica Piccioni, Pablo Tamayo, Jong Wook Kim, Eliezer M. Van Allen, Steven M. Corsello, Marzia Capelletti, Antonio Calles, Mohit Butaney, Tanaz Sharifnia, Stacey B. Gabriel, Jill P. Mesirov, William C. Hahn, Jeffrey A. Engelman, Matthew Meyerson, David E. Root, Pasi A. Jänne, Levi A. Garraway
Vydáno 2015Artigo -
20
Efficacy of a Cancer Vaccine against <i>ALK</i>-Rearranged Lung Tumors Autor Claudia Voena, Matteo Menotti, Cristina Mastini, Filomena Di Giacomo, Dario Livio Longo, Barbara Castella, Maria Elena Boggio Merlo, Chiara Ambrogio, Qi Wang, Valerio Giacomo Minero, Teresa Poggio, Cinzia Martinengo, Lucia D’Amico, Elena Panizza, Luca Mologni, Federica Cavallo, Fiorella Altruda, Mohit Butaney, Marzia Capelletti, Giorgio Inghirami, Pasi A. Jänne, Roberto Chiarle
Vydáno 2015Artigo
Vyhledávací nástroje:
Související témata
Biology
Cancer research
Medicine
Genetics
Gene
Cancer
Internal medicine
Lung cancer
Oncology
Epidermal growth factor receptor
Mutation
Kinase
Gefitinib
Biochemistry
Cell biology
Receptor
Adenocarcinoma
Malignant pleural effusion
Mutant
Crizotinib
EGFR inhibitors
Pharmacology
T790M
Anaplastic lymphoma kinase
Erlotinib
Pathology
Immunology
KRAS
Signal transduction
ALK inhibitor